The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
May 20th 2024
The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). (aflibercept). However, patent litigation has left it unclear when the biosimilars will come to market.
Improving Outcomes and Quality of Care in Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care
3.0 Credits / Ophthalmology/Optometry
View More
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars
1.0 Credit / Ophthalmology/Optometry
View More
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
2.0 Credits / Ophthalmology
View More
Dr James Auran Explains Challenges Faced by On-Call Ophthalmologists
December 27th 2021James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, discusses how a lack of providers has created a crisis in the United States.
Watch
Top 5 Most-Read Ophthalmology Stories of 2021
December 21st 2021The top 5 most-read ophthalmology articles of 2021 on AJMC.com evaluated the effectiveness of novel therapies in several ophthalmic diseases, racial/ethnic disparities in clinical trial participation, and the impact of the COVID-19 pandemic on childhood nearsightedness.
Read More
Dr Leon Herndon Outlines Ophthalmic Treatment Considerations for Older Patients
December 13th 2021Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains certain considerations ophthalmologists may need to take into account when treating older patients and the need for more specialists to meet clinical demand.
Watch
Researchers: More Studies Needed on Long-term Impact of Virtual Learning on Children's Eye Health
November 27th 2021Judith Lavrich, MD, and Jordan Hamburger discuss what additional studies need to be carried out in order to better understand the effects of virtual learning on children's long-term eye health.
Watch
Pain, Anxiety Represent Barriers to Anti-VEGF Therapies for Costly Eye Conditions
November 17th 2021Pain and fear/anxiety were the most common barriers to anti–vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration and diabetic macular edema. Another study found that those conditions had a significant impact on patients’ quality of life and Medicare costs.
Read More
Study Identifies Alcohol Use as Potential Risk Factor for AMD Subtype
November 15th 2021A new study provides genetic evidence that increased alcohol intake may be a causal risk factor for geographic atrophy, a type of advanced age-related macular degeneration (AMD), but doctors caution it may be too soon to advise patients about the risk.
Read More
Dr William Katowitz Discusses Pediatric Ophthalmic Surgical Decisions
November 13th 2021Surgical decisions with children who have ophthalmic conditions need buy in from parents, but also the children as they get older, said William Katowitz, MD, attending surgeon in the Division of Ophthalmology at Children's Hospital of Philadelphia.
Watch
Uveitic Macular Edema Increases Costs Among Patients With Noninfectious Uveitis
November 12th 2021Uveitic macular edema is common in patients with noninfectious uveitis, and its significant burden on patients and payers warrants more specific treatment guidelines to minimize quality-of-life and economic effects.
Read More
Study Finds Significant Price Transparency Concerns for Ophthalmologic Procedures
October 11th 2021An evaluation of price transparency tools for ophthalmologic procedures found significant usability, availability, and variability issues, which may disproportionately impact vulnerable populations.
Read More
Insulin Pump Use Linked With Decreased Risk of Diabetic Retinopathy in Young Patients With T1D
September 28th 2021Risk of diabetic retinopathy (DR) was found to be decreased in young patients with type 1 diabetes (T1D) who were treated with insulin pumps, with findings also indicating a 2.1-fold greater risk of DR in Black participants compared with White individuals.
Read More
Dr Rajesh Rajpal on the Future of Eye Lens Technology, Cataract Surgery
September 24th 2021Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, addresses ongoing and future innovations in eye lens technology and instruments for cataract surgery.
Watch